Construction of a community-based primary screening and hospital-based confirmatory screening pathway in pediatric
Ming-Jie Yao1, Yun-Fei Xing2, Shu-Hong Liu3
1Department of Anatomy and Embryology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Insights
Machine learning models can now predict significant fibrosis in children with nonalcoholic fatty liver disease (NAFLD). These tools offer less invasive screening, potentially reducing the need for liver biopsies in pediatric NAFLD patients.
Area of Science:
- Pediatric Hepatology
- Medical Informatics
- Non-invasive Diagnostics
Background:
- Fibrosis is a key factor in pediatric nonalcoholic fatty liver disease (NAFLD) progression.
- Accurate fibrosis assessment is crucial for managing pediatric NAFLD.
- Current diagnostic methods, like liver biopsy, are invasive.
Purpose of the Study:
- To develop and validate machine learning (ML) models for predicting significant fibrosis in Chinese children with NAFLD.
- To create less invasive screening tools for pediatric NAFLD fibrosis.
- To differentiate models for tertiary hospitals and community health centers.
Main Methods:
- A cross-sectional study included 222 (tertiary) and 101 (community) pediatric NAFLD patients with biopsy data.
- Least absolute shrinkage and selection operator (LASSO) and stepwise logistic regression identified predictive factors.
- Logistic regression (LR) and Random Forest (RF) models were constructed and compared.
Main Results:
- Simplified ATS and BIU indices were developed for tertiary and community settings, respectively.
- The RF model showed superior accuracy (0.80/0.79) over LR (0.72/0.77) in predicting fibrosis.
- RF models achieved high sensitivity and specificity, potentially avoiding liver biopsy in 60-71.4% of cases.
Conclusions:
- Novel ML-based models effectively predict significant fibrosis in pediatric NAFLD patients.
- These models serve as valuable preliminary screening tools in both hospital and community settings.
- The developed models can aid in timely risk stratification and reduce invasive procedures.
Background:
Fibrosis is a critical event in the progression of pediatric nonalcoholic fatty liver disease (NAFLD).
Aim:
To develop less invasive models based on machine learning (ML) to predict significant fibrosis in Chinese NAFLD children.
Methods:
In this cross-sectional study, 222 and 101 NAFLD children with available liver biopsy data were included in the development of screening models for tertiary hospitals and community health centers, respectively. Predictive factors were selected using least absolute shrinkage and selection operator regression and stepwise logistic regression analyses. Logistic regression (LR) and other ML models were applied to construct the prediction models.
Results:
Simplified indicators of the ATS and BIU indices were constructed for tertiary hospitals and community health centers, respectively. When models based on the ATS and BIU parameter combinations were constructed, the random forest (RF) model demonstrated higher screening accuracy compared to the LR model (0.80 and 0.79 for the RF model and 0.72 and 0.77 for the LR model, respectively). Using cutoff values of 90% for sensitivity and 90% for specificity, the RF models could effectively identify and exclude NAFLD children with significant fibrosis in the internal validation set (with positive predictive values and negative prediction values exceeding 0.80), which could prevent liver biopsy in 60% and 71.4% of NAFLD children, respectively.
Conclusion:
This study developed new models for predicting significant fibrosis in NAFLD children in tertiary hospitals and community health centers, which can serve as preliminary screening tools to detect the risk population in a timely manner.
More Related Videos
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Related Concept Videos
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Chronic Pancreatitis II: Collaborative Care
Assessment:
